Evaluation of Long-term Coronary Stenting Outcomes in Diabetic Patients With or Without Optimal Glycemic Control Referring to Tehran Heart Center Since June 2007 to June 2009
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,353
- 试验地点
- 1
- 主要终点
- Major adverse cardiac event
研究概览
简要总结
the purpose of this study is to determine whether appropriate control of diabetes around the PCI time is related with MACE and outcome of diabetic patients.
详细描述
Despite recent advances in coronary revascularization, cardiovascular disease accounts for about 75% of all hospital admissions in diabetic patients.although the introduction of drug-eluting stents has reduced the rates of restenosis after PCI, diabetic patients undergoing PCI will have poorer clinical outcomes.In this study, we sought to investigate whether a pre and post procedural glycemic control in diabetic patients,as reflected by HgbA1C prior,1 and 6 months after elective PCI,was related to major advance cardiac events (MACE) during 3 year follow up.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •age between 18-75
- •coronary stenosis > 70%
排除标准
- •Myocardial infarction in 72 hours prior to PCI
- •LVEF < 30%
- •Residual Stenosis>30%
- •Cr level > 2.0
- •hemodynamic compromise during intervention
- •Left main lesions
- •PCI for vein grafts
结局指标
主要结局
Major adverse cardiac event
时间窗: during 3 years after per-cutaneous coronary intervention
次要结局
- target vessel revascularization(during 3 years after PCI)
- target lesion revascularization(during 3 years after PCI)